Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tomislav Preveden"'
Autor:
Maja Ružić, Natalija Rajić, Milotka Fabri, Ivana Urošević, Marina Dragičević Jojkić, Tomislav Preveden, Maria Pete, Nebojša Rajić
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 13, Iss 1 (2021)
Background: Treating HCV in people with hemophilia not only prevents the development of ESLD and HCC, but it also greatly increases the quality of life for people living with hemophilia. There are many obstacles in reaching the WHO goal of globally e
Externí odkaz:
https://doaj.org/article/0a187702607b4d35a377a245ccc8def5
Autor:
Tomislav PREVEDEN, Benjamin VERES, Maja RUZIC, Maria PETE, Sanja BOGIC, Nadica KOVACEVIC, Anna C. PROCOPIO, Sharmila FAGOONEE, Francesco LUZZA, Ludovico ABENAVOLI
Publikováno v:
Minerva gastroenterology.
Liver steatosis in patients with chronic infection of hepatitis C virus (HCV) is important from multiple standpoints: faster disease progression, more frequent hepatocellular carcinoma and cirrhosis development or worse therapy response. Liver biopsy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8dc4da56947144456120b4e52a88005
https://pubmed.ncbi.nlm.nih.gov/35343668
https://pubmed.ncbi.nlm.nih.gov/35343668
Autor:
Mirjana Zivojinov, Ivana Urosevic, Zeljka Savic, Snezana Brkic, Dimitrije Damjanov, Tomislav Preveden, Dragomir Damjanov, Daniela Maric
Publikováno v:
Vojnosanitetski pregled. 77:751-753
Introduction. Suppurative gastritis (SG) is a rare disease characterized by a bacterial infection of the stomach wall. This condition has high mortality rate, especially in patients with predisposing factors such as alcoholism, immunodeficiency and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef85195ea63c4f0b856a6a247793b1a1
https://doi.org/10.2298/vsp180703134d
https://doi.org/10.2298/vsp180703134d
Publikováno v:
Vojnosanitetski Pregled, Vol 76, Iss 4, Pp 392-397 (2019)
Background/Aim. In the last two decades the incidence of recurrent Clostridium difficile infection (CDI) has risen. The aim of this study was to determine the risk factors for the recurrent CDI among patients hospitalized with the initial CDI. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54b4f9da89b9f986443de683699394b
https://doi.org/10.2298/vsp170321119k
https://doi.org/10.2298/vsp170321119k
Autor:
Maja Ružić, Rinaldo Pellicano, Maria Pete, Ludovico Abenavoli, Tomislav Preveden, Benjamin Vereš, Francesco Luzza
Publikováno v:
Minerva Medica. 111
Background Chronic hepatitis C virus (HCV) infection, that is defined by active carriage of HCV RNA in the blood, is represents one of the major public health problems worldwide. In Serbia, the prevalence of anti-HCV positive persons in the general p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71f4ff52b78dd888819f3d6c743f2ba
https://doi.org/10.23736/s0026-4806.19.06109-3
https://doi.org/10.23736/s0026-4806.19.06109-3
Publikováno v:
Vojnosanitetski pregled. :86-86
Background/Aim. Quantitative hepatitis B surface antigen (qHBsAg) has become increasingly widespread in the last few years in both diagnostic and therapeutic protocols for chronic HBV infection. Numerous studies have proposed it as a surrogate marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff9c8a907fec5a11eb599251a155852a
https://doi.org/10.2298/vsp220528086p
https://doi.org/10.2298/vsp220528086p
Publikováno v:
Vojnosanitetski Pregled, Vol 75, Iss 11, Pp 1070-1075 (2018)
Background/Aim. Hepatic steatosis in patients with chronic hepatitis C occurs in about half of the cases. Its occurrence is influenced by factors of the host and viral factors and its importance lies in the fact that it reduces the success of antivir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::767ec4a25d97d0ddaccdeafdf1837cb5
https://doi.org/10.2298/vsp161115031p
https://doi.org/10.2298/vsp161115031p
Publikováno v:
Vojnosanitetski Pregled, Vol 75, Iss 12, Pp 1233-1236 (2018)
Introduction. We are aware of the risk of late virological relapse (LVR) years after sustained viral response (SVR) by pegylated interferon and ribavirin alfa (PegIFN? + RBV) of chronic hepatitis C viral (HCV) infection. We presented three patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9110bbbb3fd581a05cb63c38f56b1467
http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700015R.pdf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700015R.pdf
Autor:
Ivana Urosevic, Natalija Rajić, Maja Ružić, Nebojsa Rajic, Milotka Fabri, Maria Pete, Tomislav Preveden, Marina Dragičević Jojkić
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases. 13:e2021058
Background Treating HCV in people with hemophilia prevents the development of end-stage liver disease (ESLD) and hepatocellular carcinoma (HCC) and greatly increases the quality of life for people living with hemophilia. There are many obstacles in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac79806b65f0515ccbf241e6c5a1d888
https://doi.org/10.4084/mjhid.2021.058
https://doi.org/10.4084/mjhid.2021.058
Publikováno v:
Vojnosanitetski Pregled, Vol 74, Iss 4, Pp 317-322 (2017)
Background/Aim. Chronic hepatitis C and liver steatosis often appear simultaneously in the same person, and steatosis can lead to worsening of liver disease and reducing the success of the treatment of chronic hepatitis C. Treatment of one disease ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795bfdfe76c069cc625f6ca4f9dd7b0e
https://doi.org/10.2298/vsp150826190p
https://doi.org/10.2298/vsp150826190p